These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 7690973

  • 1. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M, Rojas P, Kravzov J, Rios C.
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract] [Full Text] [Related]

  • 2. Partially protective effect of amantadine in the MPTP model of Parkinson's disease.
    Rojas P, Altagracia M, Kravsov J, Rios C.
    Proc West Pharmacol Soc; 1992; 35():33-5. PubMed ID: 1502234
    [No Abstract] [Full Text] [Related]

  • 3. Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
    Rausch WD, Schallauer E, Chan WW, Riederer P, Weiser M.
    J Neural Transm Suppl; 1990; 32():269-75. PubMed ID: 1708404
    [Abstract] [Full Text] [Related]

  • 4. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
    Kucherianu VG, Kryzhanovskiĭ GN, Kudrin VS, Iurasov VV, Nikushkin EV, Zhigal'tsev IV.
    Biull Eksp Biol Med; 1999 May; 127(5):502-5. PubMed ID: 10399565
    [No Abstract] [Full Text] [Related]

  • 5. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ.
    N Engl J Med; 1985 May 30; 312(22):1418-21. PubMed ID: 2581135
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Res Commun Chem Pathol Pharmacol; 1985 Oct 30; 50(1):57-65. PubMed ID: 2417293
    [Abstract] [Full Text] [Related]

  • 7. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K, Ogawa N, Sora YH.
    Res Commun Chem Pathol Pharmacol; 1988 Jan 30; 59(1):121-8. PubMed ID: 3258432
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
    Russ H, Henning K, Eckhardt H, Przuntek H.
    Arzneimittelforschung; 1985 Jan 30; 35(2):481-2. PubMed ID: 2581589
    [Abstract] [Full Text] [Related]

  • 17. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K, Sedelis M, Auburger GW, Morgan S, Huston JP, Schwarting RK.
    Exp Neurol; 2001 Mar 30; 168(1):116-22. PubMed ID: 11170726
    [Abstract] [Full Text] [Related]

  • 18. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ.
    J Neuroimmunol; 2005 Jan 30; 158(1-2):14-25. PubMed ID: 15589033
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK, Sonninen V, Riekkinen P, Laaksonen H.
    Med Biol; 1974 Jun 30; 52(3):208-17. PubMed ID: 4371255
    [No Abstract] [Full Text] [Related]

  • 20. Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
    Collins MA, Neafsey EJ, Cheng BY, Hurley-Gius K, Ung-Chhun NA, Pronger DA, Christensen MA, Hurley-Gius D.
    Adv Neurol; 1987 Jun 30; 45():179-82. PubMed ID: 3493625
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.